Cargando…
Identification of Bioactive Components from Ruellia tuberosa L. on Improving Glucose Uptake in TNF-α-Induced Insulin-Resistant Mouse FL83B Hepatocytes
Ruellia tuberosa L. (RTL) has been used as a folk medicine to cure diabetes in Asia. RTL was previously reported to alleviate hyperglycemia, insulin resistance (IR), abnormal hepatic detoxification, and liver steatosis. However, the potential bioactive compounds of RTL have still not been identified...
Autores principales: | Xu, Jian-Hua, Lo, Yangming Martin, Chang, Wen-Chang, Huang, Da-Wei, Wu, James Swi-Bea, Jhang, Yu-Yuan, Huang, Wen-Chung, Ko, Chih-Yuan, Shen, Szu-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723485/ https://www.ncbi.nlm.nih.gov/pubmed/33335557 http://dx.doi.org/10.1155/2020/6644253 |
Ejemplares similares
-
Alleviative Effect of Ruellia tuberosa L. on Insulin Resistance and Abnormal Lipid Accumulation in TNF-α-Treated FL83B Mouse Hepatocytes
por: Chen, Hong-Jie, et al.
Publicado: (2021) -
Protective effect of Ruellia tuberosa L. extracts against abnormal expression of hepatic detoxification enzymes in diabetic rats
por: Chang, Wen-Chang, et al.
Publicado: (2018) -
Effect of Ruellia tuberosa L. on aorta endothelial damage‐associated factors in high‐fat diet and streptozotocin‐induced type 2 diabetic rats
por: Ko, Chih‐Yuan, et al.
Publicado: (2019) -
Ameliorative effect of Ruellia tuberosa L. on hyperglycemia in type 2 diabetes mellitus and glucose uptake in mouse C2C12 myoblasts
por: Ko, Chih‐Yuan, et al.
Publicado: (2018) -
Alleviative effect of Ruellia tuberosa L. on NAFLD and hepatic lipid accumulation via modulating hepatic de novo lipogenesis in high‐fat diet plus streptozotocin‐induced diabetic rats
por: Huang, Da‐Wei, et al.
Publicado: (2020)